Sarbani Chaudhuri insider trades: Rocket Pharmaceuticals (RCKT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sarbani reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | RCKT | ↓ Sell | 4,701 | $3.50 | $16K | Direct | Aug 13, 2026 (2d) |
| May 7, 2026 | RCKT | ↓ Sell | 17,650 | $3.84 | $68K | Direct | May 11, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCKT insiders
Open-market trades in the last 12 months
About Sarbani Chaudhuri's insider trades
Sarbani Chaudhuri is See Remarks at Rocket Pharmaceuticals (RCKT). Since May 7, 2026, Sarbani has reported no open-market purchases and 2 sales worth $84K on SEC Form 4. In the last 12 months: 2 sales ($84K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.